- Home
- GDYN vs CSTL Comparison
GDYN vs CSTL Comparison
Compare GDYN & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDYN
- CSTL
- Stock Information
- Founded
- GDYN 2006
- CSTL 2007
- Country
- GDYN United States
- CSTL United States
- Employees
- GDYN N/A
- CSTL N/A
- Industry
- GDYN Computer Software: Prepackaged Software
- CSTL Medical Specialities
- Sector
- GDYN Technology
- CSTL Health Care
- Exchange
- GDYN Nasdaq
- CSTL Nasdaq
- Market Cap
- GDYN 648.6M
- CSTL 661.7M
- IPO Year
- GDYN N/A
- CSTL 2019
- Fundamental
- Price
- GDYN $8.10
- CSTL $24.01
- Analyst Decision
- GDYN Strong Buy
- CSTL Strong Buy
- Analyst Count
- GDYN 4
- CSTL 6
- Target Price
- GDYN $14.00
- CSTL $37.67
- AVG Volume (30 Days)
- GDYN 1.0M
- CSTL 256.3K
- Earning Date
- GDYN 10-30-2025
- CSTL 11-03-2025
- Dividend Yield
- GDYN N/A
- CSTL N/A
- EPS Growth
- GDYN N/A
- CSTL N/A
- EPS
- GDYN 0.19
- CSTL N/A
- Revenue
- GDYN $389,227,000.00
- CSTL $346,269,000.00
- Revenue This Year
- GDYN $20.79
- CSTL N/A
- Revenue Next Year
- GDYN $10.71
- CSTL N/A
- P/E Ratio
- GDYN $42.10
- CSTL N/A
- Revenue Growth
- GDYN 22.27
- CSTL 20.40
- 52 Week Low
- GDYN $7.37
- CSTL $14.59
- 52 Week High
- GDYN $25.50
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- GDYN 51.60
- CSTL 56.71
- Support Level
- GDYN $7.97
- CSTL $23.31
- Resistance Level
- GDYN $8.46
- CSTL $24.64
- Average True Range (ATR)
- GDYN 0.30
- CSTL 0.80
- MACD
- GDYN 0.04
- CSTL 0.07
- Stochastic Oscillator
- GDYN 66.02
- CSTL 69.02
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.